# OnCo record amanda-fader (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/amanda-fader/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "amanda-fader" ;
  schema:name "Amanda Nickles Fader"@en ;
  schema:description "Baltimore gynaecologic oncologist who led the trial showing that adding trastuzumab to chemotherapy helps women with HER2-positive uterine serous carcinoma, an aggressive form of endometrial cancer."@en ;
  schema:url <https://onco.cc/people/amanda-fader/> ;
  schema:dateModified "2026-09-18"^^xsd:date ;
  onco:tag "endometrial", "gynaecological", "trialist" ;
  schema:jobTitle "Gynaecologic oncologist, Johns Hopkins" ;
  onco:cancers <https://onco.cc/cancers/endometrial-p53-abnormal/>, <https://onco.cc/cancers/endometrial/> ;
  onco:institutions <https://onco.cc/institutions/johns-hopkins/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-fader-trastuzumab-uterine-serous-jco-2018/> ;
  schema:affiliation <https://onco.cc/institutions/johns-hopkins/> .
